Nutrigenomics is the study of the effects of nutrients on the expression of the genetic makeup of people. Today, the definition of nutrigenomics has changed, or rather become broader, with the comprehensive inclusion of nutritional factors protecting the genome from suffering a damage. It basically concerns with the impact of dietary components on the metabolome, proteome, and genome. There are several types of tools such as clinical data, genomic assays, biomarkers, and food diaries used in nutrigenomics to determine the risk and progression of diseases.
The approaches used in nutrigenomics are applied to a broad array of health conditions. For example, nutrigenomics can be used to find a correlation between specific diseases and nutrient intake and links between mental health, obesity, and gut microbiota.
Vendors operating in the global nutrigenomics market are expected to focus on improving their operational performance through improved employee engagement, which also puts a good impression on consumers. In April 2019, LifeVantage, an American pioneer in nutrigenomics, received the honor of ‘Best Places to Work’ in the direct selling industry for the third time in a row.
Our report on the global nutrigenomics market provides a highly reliable, detailed, and accurate research study that will help players to improve sales and gain strong growth in the coming years.
Key Players
“BASF, Royal DSM, Danone, WellGen, GeneSmart, Cura Integrative Medicine, Unilever, Genova Diagnostics, Nutrigenomix, Inc., Cell Logic, Metagenics, and XCODE Life Science Pvt. Ltd.”
Get PDF template of this report: https://www.qyrconsulting.com/request-sample/5673
Market Dynamics
The global nutrigenomics market is projected to grow at a remarkable CAGR during the forecast period 2019-2025. One of the important growth factors of the global market could be the rising awareness about nutrigenomics among consumers. Increasing incidence of obesity-related diseases is also expected to push the demand for nutrigenomics. The global market is anticipated to expand on the back of a growing number of athletes wanting to follow personalized diet plans. Personalized diet is one of the fast-growing trends observed in the global market. Increasing significance of consuming nutritious foods to prevent malnutrition, cardiovascular disease, obesity, and related diseases is foretold to augment the demand in the global market.
A decent number of scientists have emphasized on diet regulation as a means to decrease the susceptibility to chronic diseases such as cancer. This has encouraged more research on cancer that is based on the importance of nutrition. On the other hand, there are some factors predicted to hamper the growth of the global nutrigenomics market. For instance, lack of proven results that could support nutrigenomics studies and low number of regulatory approvals are foreseen to cut back the demand in the global market.
Market Segmentation
By Application
- Cardiovascular Diseases
- Obesity
- Cancer Research
Among key applications of nutrigenomics, obesity is projected to dominate the global market due to the rising incidence of the disorder. Nutritionists and physicians are putting strong emphasis on consuming nutritious foods to fight obesity. This is expected to increase the demand in the global nutrigenomics market.
Report TOC, Figures and Tables: https://www.qyrconsulting.com/reports/global-nutrigenomics-market
Table of Contents
Overview of the Report: The report starts with research scope, major players studied by the authors, years considered for the research study, objectives of the study, and analysis of market share by application and market size growth rate by type.
Global Growth Trends: Here, the size of the global Bio-pharma market is studied along with sales and revenue analysis. This section also includes industry trends and analysis of the growth rate of the global Bio-pharma market by region.
Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of revenue, sales, and share in the global Bio-pharma market.
Company Profiles: Almost all leading companies operating in the global Bio-pharma market are profiled in this section, taking into account their recent developments, market share, and other vital factors.
Market Forecast: Apart from revenue and sales forecast of the global Bio-pharma market, this section provides forecast of all
About Us:
We established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.
